Atlas Trials

Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck.

Clinical trial NCT02882308 · COMPLETED

Trial details

NCT number
NCT02882308
Sponsor
Hellenic Cooperative Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Squamous Cell Carcinoma of the Head and Neck
Start date
2016-10-20
Primary completion
2019-12-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.